STAMFORD, Conn., March 16, 2023 (GLOBE NEWSWIRE) -- GeneDx Holdings Corp. (GeneDx) (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, announced new ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

A key milestone for personalized medicine has been achieved by two Roche Applied Science companies, Roche NimbleGen and 454 Life Sciences, in developing revolutionary technologies to resequence all ...

Researchers at Baylor College of Medicine and Roche NimbleGen Inc. have published details of an efficient and cost-effective method for capturing targeted regions of the genome via NimbleChip™ ...

(MENAFN- GlobeNewsWire - Nasdaq) The Precision Medicine Market in the U.S. is projected to grow from $26.58 billion in 2024 to $62.82 billion by 2033, with a CAGR of 10.03%. Key drivers include ...

Dublin, Dec. 19, 2024 (GLOBE NEWSWIRE) -- The "Protein Microarrays - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Protein ...